Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.
JavaScript is disabled for your browser. Some features of this site may not work without it.
Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.
Soulieres, D; Ford, J; Rabault, B; Ressayre-Djaffer, C; Gattermann, N; Cunningham, M; Angelucci, E; Turlin, B; Canatan, D; Mangiagli, A; De Sanctis, V; Meddeb, B; Rose, C